Cell Source, Inc.

CLCS · OTC
Analyze with AI
12/31/2024
9/30/2024
6/30/2024
3/31/2024
Operating Activities
Net Income-$590-$1,417-$1,489-$1,275
Dep. & Amort.$0$107$0$5
Deferred Tax$0$0$0$0
Stock-Based Comp.$0-$267$15$289
Change in WC$186$125$280$887
Other Non-Cash-$344$814$71-$79
Operating Cash Flow-$748-$639-$1,123-$174
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.-$527-$4$1,214$147
Stock Issued$1,376$416$20$25
Stock Repurch.$0$0$0$0
Dividends Paid$0-$691-$327-$327
Other Fin. Act.-$49$550-$726$307
Financing Cash Flow$800$571$1,214$152
Forex Effect$0$0$0$0
Net Chg. in Cash$52-$68$91-$22
Supplemental Information
Beg. Cash$23$91$0$22
End Cash$75$23$91$0
Free Cash Flow-$748-$639-$1,123-$174
Cell Source, Inc. (CLCS) Financial Statements & Key Stats | AlphaPilot